North Carolina Agriculture and Technical State University/ NRI Building
Kannapolis, North Carolina, 28081, United States
Location status: Recruiting
NCT Number: NCT07767149
This randomized crossover study will compare low- and high-flavonoid diets in healthy adults to identify flavonoid-derived biomarkers in urine and plasma. Using targeted LC-MS metabolomics, researchers will measure known and novel flavonoid metabolites and evaluate whether a higher flavonoid intake reduces carbonyl stress markers, including reactive carbonyl species (RCS) and advanced glycation end products (AGEs).
Interested in participating?
Request Info25 year–70 year
All sexes
Interventional
Not applicable
Kannapolis, North Carolina, 28081, United States
Location status: Recruiting
Biomarkers of flavonoids and flavonoid-rich foods are needed to monitor diets. Monitoring diets and associating dietary patterns with health risks and outcomes is an essential step in the research process. The goal of this study is to determine the time- and dose-dependent formation of novel flavonoid metabolites in urine and plasma samples by conducting a randomized crossover trial of two dietary interventions with low (~140 mg flavonoids/day) and high (~420 mg flavonoids/day) flavonoid diets among healthy individuals.
Foods with high or low flavonoid content will be incorporated into participants' usual diets. LCMS-based targeted metabolomics will be used to assess flavonoid metabolites, including novel RCS-conjugated and oxidized flavonoid metabolites, and to determine whether consuming a flavonoid-rich diet will lead to a decrease in carbonyl stress as measured by RCS and related advanced glycation end products (AGEs). We will determine the changes in the major RCS and related AGEs after each intervention period using LCMS and examine the relationship between changes in RCS and AGEs and the formation of flavonoid RCS conjugates
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Major brands Notes Soy Isoflavones All flavonoid-enriched supplements should be avoided. Lipo-Flavonoid Citrus Bioflavonoids Complex Super Flavonoids Super Antioxidants Quercetin Supplement Essential-C and flavonoids Milk Thistle Other flavonoids supplements, including but not limited: Luteolin, Rutin, etc
<!-- -->
Exclusion criteria
Participants will consume the high-flavonoid diet daily for 3 weeks. The diet includes 1 Red Delicious apple (approximately 160 g), freeze-dried whole blueberry powder (25 g), soy milk (240 mL), and decaffeinated Lipton green tea ( 2 g tea leaves), providing approximately 420 mg flavonoids per day.
Participants will consume the low-flavonoid diet daily for 3 weeks. The diet includes 1/3 of Red Delicious, 107 g of pineapple; 8.3 g of blueberry powder plus 16.7 g of blueberry placebo powder; 80 mL of soy milk plus 160 mL of 2% low-fat milk; and 0.67 g tea leaves, providing approximately 140 mg flavonoids per day.
Time frame: After the 3-week dietary intervention period.
Change in plasma and urine concentrations of flavonoid metabolites, including reactive carbonyl species (RCS)-conjugated flavonoid metabolites, measured by LC-MS.
Time frame: After the 3-week dietary intervention
Association between changes in urinary reactive carbonyl species and the formation of flavonoid RCS-conjugated metabolites measured by LC-MS.
Contact information is provided by the study sponsor or research team.
North Carolina Agriculture & Technical State University
Other
Effects of Flavonoid-rich Foods on Carbonyl Stress
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03911050
Human Health, Pharmacokinetics
Kannapolis, North Carolina, United States
View Trial DetailsNCT05773794
Human Health, Polyphenols
Kannapolis, North Carolina, United States
View Trial DetailsNCT04335435
Human Health, Pharmacokinetics
View Trial DetailsNCT07341789
Behavior, Behavioral Symptoms
La Ñora, Murcia, Spain
View Trial Details